Clarithromycin 250mg
Active substance: slarithromycin;
1 coated tablet contains clarithromycin in terms of 100% substance 250 mg or 500 mg
Excipients: lactose, corn starch, colloidal silicon dioxide, talc, magnesium stearate, titanium dioxide, hydroxypropylmethylcellulose, polyethylene glycol 6000, quinoline yellow.
dosage form
Coated tablets.
Clarithromycin 250mg
Antimicrobial medications for regular use. Macrolides. ATC code J01F A09.
testimony
Treatment of infections caused by microorganisms sensitive to clarithromycin.
Lower respiratory tract infections (bronchitis, pneumonia).
Upper respiratory tract infections (sinusitis, pharyngitis).
Infections of skin and soft tissue (folliculitis, pseudoerysipelas).
Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium chelonae, Mycobacterium fortuitum or Mycobacterium kansasii.
Prevention of disseminated infections caused by Mycobacterium avium complex (MAC) in HIV-infected patients with the number of CD 4 count ? 100 / mm 3.
Clarithromycin 250mg
Eradication of H. pylori in patients with duodenal ulcer in the oppression of secretion of hydrochloric acid, which is produced by omeprazole or lansoprazole (clarithromycin activity against H. pylori higher at neutral pH, it than at acidic pH).
The treatment of odontogenic infections.